Resources and Support

Shire: Committed to the hemophilia community for over 60 years

A legacy focused on patients, research, and innovation

Shire is focused on providing support and resources for the hemophilia community. Our dedication and commitment to providing programs and services for the community helps positively impact the lives of people with bleeding disorders.

PATIENTS

Unmatched support, resources, and programs to make meaningful differences, one person at a time

RESEARCH

Pioneering treatments to reduce and eliminate bleeds and improve quality of life. Ongoing clinical trials are currently under way, related to multiple bleeding disorders 8-10

INNOVATION

Pursuing innovation, such as increasing time between infusions

Connecting with the unique programs Shire provides can help you reach your goals

Shire's CoPay Assistance Program: This program offers CoPay, Coinsurance, and Deductible support to eligible hemophilia patients with commercial insurance, regardless of household income. Enrollment is quick and easy.

Call 1-888-229-8379 and answer a few simple questions about yourself and your pharmacy.
Visit hematologysupport.com for more information, as well as full Terms and Conditions for Shire's CoPay Assistance Program.

Inquire Today to See if You Are Eligible to Get 4 Free Doses of RIXUBIS®*

Make Your Move and Enroll in the RIXUBIS Free Trial Program in Just 3 Easy Steps

  1. Download and complete the enrollment form with your healthcare provider
  2. Fax the completed form to 1-866-467-7740
  3. Experience the benefits of RIXUBIS

By enrolling in the FREEDOM OF CHOICETM Free Trial Program for RIXUBIS you may be eligible to receive 4 free doses of RIXUBIS* along with valuable educational resources. Download and complete the FREEDOM OF CHOICE enrollment form for RIXUBIS with your healthcare provider to get started today.

*Free Trial Program is for new RIXUBIS patients only. Participants must receive consultation and approval from a healthcare provider.

+

Important Risk Information for RIXUBIS [Coagulation Factor IX (Recombinant)]

Please read below for Indications and Detailed Important Risk Information for RIXUBIS. See full Prescribing Information.

Indications for RIXUBIS [Coagulation Factor IX (Recombinant)]

RIXUBIS is an injectable medicine used to replace clotting factor IX that is missing in adults and children with hemophilia B (also called congenital factor IX deficiency or Christmas disease).

RIXUBIS is used to control and prevent bleeding in people with hemophilia B. Your healthcare provider may give you RIXUBIS when you have surgery. RIXUBIS can reduce the number of bleeding episodes when used regularly (prophylaxis).

Detailed Important Risk Information for RIXUBIS [Coagulation Factor IX (Recombinant)]

You should not use RIXUBIS if you are allergic to hamsters or any ingredients in RIXUBIS.

You should tell your healthcare provider if you have or have had any medical problems, take any medicines, including prescription and non-prescription medicines, such as over-the-counter medicines, supplements or herbal remedies, have any allergies, including allergies to hamsters, are nursing, are pregnant or planning to become pregnant, or have been told that you have inhibitors to factor IX.

Allergic reactions have been reported with RIXUBIS. Call your healthcare provider or get emergency treatment right away if you get a rash or hives, itching, tightness of the throat, chest pain or tightness, difficulty breathing, lightheadedness, dizziness, nausea, or fainting.

Your body may form inhibitors to factor IX. An inhibitor is part of the body's defense system. If you form inhibitors, it may stop RIXUBIS from working properly. Consult with your healthcare provider to make sure you are carefully monitored with blood tests for development of inhibitors to factor IX.

If you have risk factors for developing blood clots, the use of factor IX products may increase the risk of abnormal blood clots.

Common side effects that have been reported with RIXUBIS include: unusual taste in the mouth, limb pain, and atypical blood test results.

Call your healthcare provider right away about any side effects that bother you or if your bleeding does not stop after taking RIXUBIS.

Please see RIXUBIS full Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.